Re: Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie's Disease
- PMID: 25923159
Re: Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie's Disease
Comment in
-
Reply by Author.Urol J. 2015 Mar-Apr;12(2):2114. Urol J. 2015. PMID: 26121772 No abstract available.
Comment on
-
Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie's Disease.Urol J. 2015 Apr 29;12(2):2105-10. Urol J. 2015. PMID: 25923158
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical